UY32896A - Composiciones de enzimas pancreáticas y métodos para tratar pancreatitis e insuficiencia pancreática - Google Patents

Composiciones de enzimas pancreáticas y métodos para tratar pancreatitis e insuficiencia pancreática

Info

Publication number
UY32896A
UY32896A UY0001032896A UY32896A UY32896A UY 32896 A UY32896 A UY 32896A UY 0001032896 A UY0001032896 A UY 0001032896A UY 32896 A UY32896 A UY 32896A UY 32896 A UY32896 A UY 32896A
Authority
UY
Uruguay
Prior art keywords
pancreatic
compositions
methods
enzymes
insufficiency
Prior art date
Application number
UY0001032896A
Other languages
English (en)
Spanish (es)
Inventor
Gopi M Venkatesh
Perrett Stephen
Ruth Thieroff-Ekerdt
Efthymiopoulos Konstantino
Original Assignee
Eurand Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43730817&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UY32896(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Eurand Pharmaceuticals Ltd filed Critical Eurand Pharmaceuticals Ltd
Publication of UY32896A publication Critical patent/UY32896A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2813—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
UY0001032896A 2009-09-17 2010-09-17 Composiciones de enzimas pancreáticas y métodos para tratar pancreatitis e insuficiencia pancreática UY32896A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US24346709P 2009-09-17 2009-09-17

Publications (1)

Publication Number Publication Date
UY32896A true UY32896A (es) 2011-02-28

Family

ID=43730817

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001032896A UY32896A (es) 2009-09-17 2010-09-17 Composiciones de enzimas pancreáticas y métodos para tratar pancreatitis e insuficiencia pancreática

Country Status (23)

Country Link
US (2) US8784884B2 (cg-RX-API-DMAC7.html)
EP (1) EP2477645B1 (cg-RX-API-DMAC7.html)
JP (1) JP5877399B2 (cg-RX-API-DMAC7.html)
KR (1) KR101771752B1 (cg-RX-API-DMAC7.html)
CN (2) CN105214073A (cg-RX-API-DMAC7.html)
AR (1) AR078291A1 (cg-RX-API-DMAC7.html)
AU (1) AU2010295494B2 (cg-RX-API-DMAC7.html)
BR (1) BR112012005837A8 (cg-RX-API-DMAC7.html)
CA (1) CA2774269C (cg-RX-API-DMAC7.html)
CL (1) CL2012000658A1 (cg-RX-API-DMAC7.html)
CO (1) CO6531419A2 (cg-RX-API-DMAC7.html)
ES (1) ES2690661T3 (cg-RX-API-DMAC7.html)
HK (1) HK1218886A1 (cg-RX-API-DMAC7.html)
IL (2) IL218656A (cg-RX-API-DMAC7.html)
MX (1) MX2012003214A (cg-RX-API-DMAC7.html)
MY (1) MY161843A (cg-RX-API-DMAC7.html)
NZ (1) NZ599143A (cg-RX-API-DMAC7.html)
RU (1) RU2570376C2 (cg-RX-API-DMAC7.html)
SA (1) SA110310695B1 (cg-RX-API-DMAC7.html)
TW (2) TW201639545A (cg-RX-API-DMAC7.html)
UY (1) UY32896A (cg-RX-API-DMAC7.html)
WO (1) WO2011035079A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201202761B (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1319655B1 (it) 2000-11-15 2003-10-23 Eurand Int Microsfere di enzimi pancreatici con elevata stabilita' e relativometodo di preparazione.
CN101686943B (zh) 2007-02-20 2014-03-26 阿普塔利斯制药有限公司 稳定的消化酶组合物
US10087493B2 (en) 2008-03-07 2018-10-02 Aptalis Pharma Canada Ulc Method for detecting infectious parvovirus in pharmaceutical preparations
EP2818160B1 (en) * 2010-10-01 2017-11-08 Aptalis Pharma Limited Enteric coated, low-strength pancrelipase formulations
KR101953413B1 (ko) 2011-08-08 2019-02-28 앨러간 파마슈티컬스 인터내셔널 리미티드 소화효소들을 함유하는 고형 조성물들의 용해 시험 방법
ES2784227T3 (es) 2013-08-09 2020-09-23 Allergan Pharmaceuticals Int Ltd Composición de enzimas digestivos adecuada para la administración entérica
WO2015193730A1 (en) 2014-06-19 2015-12-23 Aptalis Pharma Ltd. Methods for removing viral contaminants from pancreatic extracts
FR3079146B1 (fr) * 2018-03-23 2020-04-17 Karim Ioualalen Formulation gastroprotectrice de complexes d’enzymes permettant de restaurer la fonction digestive.
WO2021202363A1 (en) * 2020-03-30 2021-10-07 Wall Jai Combined animal-derived and synthetically produced pancreatic enzyme replacement therapy

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1509866A (en) 1975-06-10 1978-05-04 Johnson & Johnson Enteric coated digestive enzyme compositions
US4447412A (en) * 1983-02-01 1984-05-08 Bilton Gerald L Enzyme-containing digestive aid compostions
US5578304A (en) 1992-06-22 1996-11-26 Digestive Care Inc. Compositions of digestive enzymes and salts of bile acids and process for preparation thereof
US5260074A (en) 1992-06-22 1993-11-09 Digestive Care Inc. Compositions of digestive enzymes and salts of bile acids and process for preparation thereof
US5460812A (en) 1992-06-22 1995-10-24 Digestive Care Inc. Compositions of digestive enzymes and salts of bile acids and process for preparation thereof
US5302400A (en) 1992-06-22 1994-04-12 Digestive Care Inc. Preparation of gastric acid-resistant microspheres containing digestive enzymes and buffered-bile acids
DE4227385A1 (de) 1992-08-19 1994-02-24 Kali Chemie Pharma Gmbh Pankreatinmikropellets
EP0879048B2 (en) 1996-02-09 2009-07-29 Quadrant Drug Delivery Limited Method for making tablets using trehalose
US5750104A (en) 1996-05-29 1998-05-12 Digestive Care Inc. High buffer-containing enteric coating digestive enzyme bile acid compositions and method of treating digestive disorders therewith
US20010046493A1 (en) 2000-02-24 2001-11-29 Alex Margolin Lipase-containing composition and methods of use thereof
CN1156308C (zh) * 2002-04-19 2004-07-07 北京世诺医药科技有限公司 多酶组合胶囊
US20040121010A1 (en) * 2002-10-25 2004-06-24 Collegium Pharmaceutical, Inc. Pulsatile release compositions of milnacipran
EP1596838A2 (en) 2003-02-11 2005-11-23 Torrent Pharmaceuticals Ltd Once a day orally administered pharmaceutical compositions comprising a proton pump inhibitor and a prokinetic agent
AU2004285558A1 (en) 2003-10-29 2005-05-12 Altus Pharmaceuticals Inc. Non-pancreatic proteases for controlling plasma cholecystokinin (CCK) concentration and for treating pain
US7387793B2 (en) 2003-11-14 2008-06-17 Eurand, Inc. Modified release dosage forms of skeletal muscle relaxants
US7470435B2 (en) 2003-11-17 2008-12-30 Andrx Pharmaceuticals, Llc Extended release venlafaxine formulation
RU2381813C2 (ru) 2004-03-22 2010-02-20 Зольвай Фармасьютиклз Гмбх Пероральные фармацевтические композиции на основе продуктов, содержащих липазы, прежде всего панкреатин, и пав
WO2005115445A1 (en) * 2004-05-24 2005-12-08 Novozymes A/S Enzymes for pharmaceutical use
DE602005022471D1 (de) * 2004-10-14 2010-09-02 Altus Pharmaceuticals Inc Zusammensetzungen enthaltend lipase, protease und amylase zur behandlung von pankreasinsuffizienz
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
MX2007015472A (es) * 2005-06-24 2008-04-17 Novozymes As Lipasas para uso farmaceutico.
US20070025977A1 (en) 2005-07-21 2007-02-01 Mulberg Andrew E Method of treating steatorrhea in infants
CA2616943C (en) 2005-07-29 2016-04-12 Solvay Pharmaceuticals Gmbh Processes for the manufacture of sterilized pancreatin powder
US11266607B2 (en) * 2005-08-15 2022-03-08 AbbVie Pharmaceuticals GmbH Process for the manufacture and use of pancreatin micropellet cores
US9198871B2 (en) 2005-08-15 2015-12-01 Abbott Products Gmbh Delayed release pancreatin compositions
WO2007053619A2 (en) * 2005-11-01 2007-05-10 Bio-Cat, Inc. A composition with a fungal (yeast) lipase and method for treating lipid malabsorption in cystic fibrous as well as people suffering from pancreatic lipase insufficiency
MX2008015031A (es) * 2006-05-26 2008-12-05 Nestec Sa Metodos de uso y composiciones nutritivas de extracto de touchi.
US20080199448A1 (en) * 2007-02-16 2008-08-21 Ross Mairi R Enzyme composition for improving food digestion
CN101686943B (zh) 2007-02-20 2014-03-26 阿普塔利斯制药有限公司 稳定的消化酶组合物
US20090117180A1 (en) * 2007-02-20 2009-05-07 Giovanni Ortenzi Stable digestive enzyme compositions
EP2328566A1 (en) 2008-09-30 2011-06-08 DSM IP Assets B.V. Enzyme composition and application thereof in the treatment of pancreatic insufficiency

Also Published As

Publication number Publication date
NZ599143A (en) 2014-05-30
JP2013505255A (ja) 2013-02-14
CO6531419A2 (es) 2012-09-28
US20140287035A1 (en) 2014-09-25
IL218656A0 (en) 2012-05-31
CA2774269A1 (en) 2011-03-24
ES2690661T3 (es) 2018-11-21
TW201113052A (en) 2011-04-16
CL2012000658A1 (es) 2012-09-28
US20110064799A1 (en) 2011-03-17
EP2477645A1 (en) 2012-07-25
EP2477645B1 (en) 2018-08-15
TW201639545A (zh) 2016-11-16
BR112012005837A8 (pt) 2017-10-10
EP2477645A4 (en) 2014-06-25
US20160051472A9 (en) 2016-02-25
RU2570376C2 (ru) 2015-12-10
AU2010295494A1 (en) 2012-03-29
CN102630164B (zh) 2015-09-16
CN105214073A (zh) 2016-01-06
SA110310695B1 (ar) 2014-11-26
ZA201202761B (en) 2012-12-27
BR112012005837A2 (pt) 2017-05-30
IL218656A (en) 2017-12-31
RU2012113253A (ru) 2013-10-27
CN102630164A (zh) 2012-08-08
US8784884B2 (en) 2014-07-22
CA2774269C (en) 2017-03-21
KR101771752B1 (ko) 2017-08-25
IL245875A0 (en) 2016-07-31
HK1218886A1 (zh) 2017-03-17
JP5877399B2 (ja) 2016-03-08
MX2012003214A (es) 2012-08-01
AU2010295494B2 (en) 2014-09-25
AR078291A1 (es) 2011-10-26
MY161843A (en) 2017-05-15
TWI572372B (zh) 2017-03-01
WO2011035079A1 (en) 2011-03-24
KR20120100915A (ko) 2012-09-12

Similar Documents

Publication Publication Date Title
UY32896A (es) Composiciones de enzimas pancreáticas y métodos para tratar pancreatitis e insuficiencia pancreática
PH12015502362A1 (en) Certain chemical entities, compositions and methods
IN2012DN01869A (cg-RX-API-DMAC7.html)
BRPI0516515A (pt) composições contendo lipase, protease e amilase para o tratamento da insuficiência pancreática
EA201170349A1 (ru) Модуляторы mif
CR20140422A (es) Composiciones de enzima digestiva estable
GB2511713A (en) Methods of treating behavioral symptoms of neurological and mental disorders
MX2010007846A (es) Fabricación de enzimas sulfatasa lisosomal humana altamente fosforilada, activa y usos de las mismas.
IL209979A0 (en) Use of hsp70 as a regulator of enzymatic activity
MY168762A (en) Certain chemical entities, compositions and methods
MX342128B (es) Compuestos farmaceuticos.
TN2010000122A1 (en) Compounds and compositions as modulators of gpr119 activity
BRPI0808775A2 (pt) compostos e composições como moduladores de atividade de gpr119
UA114090C2 (uk) Сполуки, що інгібують металоферменти
GB0920703D0 (en) Compositions containing satiogens and methods of use
WO2011140202A3 (en) Mif modulators
EA201291107A1 (ru) Соединения, ингибирующие металлоферменты
MX2012004078A (es) Compuestos y composiciones como moduladores de la actividad de gpr119.
MX2009011215A (es) Derivados de triazolopiridina carboxamida, su preparacion y su aplicacion terapeutica.
GB201202561D0 (en) Treatment of skin disorders
MX2022004373A (es) Celulas madre modificadas y metodos de uso de las mismas.
MX2010001813A (es) Metodos y composiciones para el tratamiento de canceres.
ECSP088764A (es) Métodos para tratar trastornos cognitivos y otros afines
WO2011106785A3 (en) Methods of identifying agents effective to treat cognitive decline and diseases associated therewith
WO2011097327A3 (en) Compositions and methods of modulating receptor protein tyrosine phosphatases

Legal Events

Date Code Title Description
RDES Application refused

Effective date: 20210602